Uae Ivf Drugs And Food Supplements Supplements Market is Estimated to Witness High Growth by Size, Share and forecast by 2031 | Shinelife, Adorefem, LG Chem

The Uae Ivf Drugs And Food Supplements Market is estimated for 2024 for the forecast period 2024-2031, as highlighted in a new report published by Coherent Market Insights.

Market Overview:

The UAE IVF drugs and food supplements market involves medications and supplements that help enhance fertility in females and males undergoing IVF/ART treatment. IVF enables fertilization to occur outside the body. Some key products include fertility drugs for ovarian stimulation, male fertility supplements, and preimplantation genetic diagnosis.

Market Dynamics:

The UAE IVF drugs and food supplements market is expected to witness significant growth over the forecast period, driven by rising awareness about infertility treatment options and growing preference for IVF. According to the Middle East Fertility Society, infertility affects approximately 15-20% of married couples in the UAE. Furthermore, changing lifestyles and late pregnancies have also contributed to the rise in infertile couples opting for IVF. Majority of key players are focusing on product innovation and development of drugs with lesser side effects to gain a competitive edge in the market. For instance, in 2023 Origo Fertility launched OvaBoost, an evidence-based food supplement designed to support egg and embryo quality in women undergoing IVF treatment.

Request a Sample Copy of the Report @ https://www.coherentmarketinsights.com/insight/request-sample/4939

Growth in infertility rates is driving the growth of the IVF drugs and food supplements market in UAE

The rates of infertility have been steadily rising over the past few decades in UAE. According to a study conducted by a top fertility clinic in Dubai, around 1 in 4 couples in UAE face difficulty in conceiving naturally. Increasing stress levels, changing lifestyles, rising pollution and other environmental factors have contributed to this rise in infertility. As more people are unable to conceive, the demand for assisted reproductive technologies like IVF has increased dramatically. IVF involves stimulation of ovaries to develop multiple mature follicles and eggs which are later fertilized in a laboratory setting. Drugs and supplements play a crucial role in IVF treatment for stimulating follicle development and egg maturation. Several cycles may be required to achieve successful pregnancy which further drives the recurrent use of IVF drugs and supplements. Many clinics have also started early intervention programs which involve use of fertility drugs and supplements even before embarking on the actual IVF procedure. This has boosted the volumes in the market.

Rising awareness and medical reimbursement is boosting IVF treatment rates

Various government initiatives and extensive media coverage has significantly raised awareness about infertility and assisted reproduction in UAE in recent times. This has helped in removing the social stigma around infertility to some extent. People are now more open to discussing their fertility issues and seeking medical help. The authorities have also introduced partial to full medical insurance coverage for defined IVF cycles which has made treatment more affordable. Major health insurers like Daman and Emirates have included fertility treatment under their medical plans. This has provided a huge encouragement for people to opt for IVF rather than considering it as last resort. Greater affordability means more cycles per patient on an average which translates to increased consumption of related drugs and supplements.

Top Companies Covered In This Report: Shinelife, Adorefem, LG Chem, Adorshea, Biofield Pharma, Medibyte, Mestra Pharma, Dr. D Pharma, Abbott, Zydus, Takeda Pharmaceutical Company Limited, Merck KGaA, and Ferring B.V.

Market Segmentation:

By Product Type: Drugs (Clomiphene, Injectable Hormones (Human chorionic gonadotropin (hCG), Follicle-stimulating hormone (FSH), Human menopausal gonadotropin (hMG), Gonadotropin-releasing hormone (GnRH), GnRH agonist, GonGnRH antagonist), Food Supplements)

By Distribution Channel: Hospitals Pharmacies, Retail Pharmacies, Online Pharmacies

Geographically, the detailed analysis of consumption, revenue, UAE Ivf Drugs And Food Supplements Market share, growth rate, etc. of the following regions:

» North America (United States, Canada, and Mexico)
» Europe (Germany, France, UK, Russia, Italy)
» Asia-Pacific (China, Japan, Korea, India, and Southeast Asia)
» Latin America (Brazil, Argentina, Colombia)
» Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, and South Africa)

Lack of fresh egg donors is a major restraint for the IVF market in UAE

While demand for IVF is growing rapidly in UAE, finding adequate number of young and healthy egg donors is proving to be a major challenge. As per national guidelines, only women aged 21-35 years who have had at least one live birth of their own can serve as oocyte donors. However, not many Emirati women are willing to undergo the emotionally demanding donor process. Cultural and religious sensitivities also make many potential donors reluctant. Most clinics therefore rely on foreign egg donors from countries like Ukraine, Russia and Romania who are flown in when required. However, this process is complex, costly and puts treatment timeline under stress. It also raises issues around legal ownership rights over remaining embryos. The relative lack of fresh and quality egg donors restricts the number of IVF cycles that can be supported sustainably in UAE each year. This acts as a restraint on the growth potential of the overall IVF market including drugs and supplements segment.

Increasing trend of fertility preservation provides opportunities

With more emphasis on women's education and career, many Emirati women are delaying motherhood till their late 30s or even early 40s. At the same time, availability of fertility preservation techniques like egg, embryo and ovarian tissue freezing has risen sharply. These techniques allow women to freeze and store their eggs or embryos when they are young for use later in life. The number of women opting for egg freezing is on the rise to circumvent age related fertility decline issues. Similarly, cancer patients are increasingly freezing their gametes before starting chemotherapy or radiation treatment which can damage reproductive abilities. This trend provides substantial opportunities for growth in sales of fertility preservation drugs which are similar to the ones used for IVF stimulation. It also ensure recurrent long term usage from the frozen inventories in the coming years. Overall fertility preservation is emerging as an important new revenue stream for IVF drug makers.

Growing trend towards natural and organic supplements

In general, people in UAE are becoming more health and wellness conscious. They prefer using natural or herbal supplements over synthetic medication wherever possible. This trend is also visible in fertility space where women undergoing IVF or using fertility drugs want to take additional supplements to boost their overall wellbeing. There is growing popularity of supplements containing ingredients like coenzyme Q10, omega 3 fatty acids, vitamins D, E and antioxidants which are believed to improve egg and embryo quality as well as endometrial lining. Moreover, many supplements provide support for oxidative stress and inflammation associated with IVF treatment.

Direct Buy This Premium Research Report @ https://www.coherentmarketinsights.com/insight/buy-now/4939

Reason to Buy Our Market Research Report:

- Enhance your decision-making capability in a more rapid and time-sensitive manner.
- Identify key growth and investment opportunities in the Thrombolytic Therapy market.
- Facilitate decision-making based on strong historic and forecast data for the Thrombolytic Therapy market.
- Position yourself to gain the maximum advantage of the industry's growth potential.
- Identify key partners and business development avenues.
- Understand and respond to your competitors' business structure, strategy, and prospects

𝐅𝐀𝐐'𝐬

Q.1 What are the main factors influencing the UAE Ivf Drugs And Food Supplements market?
Q.2 Which companies are the major sources in this industry?
Q.3 What are the market's opportunities, risks, and general structure?
Q.4 Which of the top UAE Ivf Drugs And Food Supplements Market companies compare in terms of sales, revenue, and prices?
Q.5 Which businesses serve as the UAE Ivf Drugs And Food Supplements market's distributors, traders, and dealers?
Q.6 How are market types and applications and deals, revenue, and value explored?
Q.7 What does a business area's assessment of agreements, income, and value implicate?

We Offer Customized Report, Click @ https://www.coherentmarketinsights.com/insight/request-customization/4939

Contact Us:

Mr. Shah

Coherent Market Insights Pvt. Ltd,
📞Phone: U.S.: +1-206-701-6702
📞U.K.: +44-020-8133-4027
📞JAPAN: +81-50-5539-1737
📞INDIA: +91-848-285-0837
✉ Email: sales@coherentmarketinsights.com

𝐀𝐛𝐨𝐮𝐭 𝐔𝐬:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having sales office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 57 countries worldwide. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.

This release was published on openPR.